Simplex Trading’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,062
Closed -$188K 10306
2023
Q2
$188K Sell
4,062
-3,915
-49% -$135K ﹤0.01% 4369
2023
Q1
$228K Buy
7,977
+3,959
+99% +$117K ﹤0.01% 4177
2022
Q4
$125K Buy
+4,018
New +$131K ﹤0.01% 4801
2022
Q3
Sell
-7,277
Closed -$133K 11249
2022
Q2
$112K Sell
7,277
-3,566
-33% -$61.3K ﹤0.01% 5430
2022
Q1
$207K Buy
+10,843
New +$194K ﹤0.01% 5104

Simplex Trading's DICE Position: Q3 2023 in Review

Simplex Trading sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 4,062 shares — an estimated $188K sold.

Simplex Trading first reported a position in DICE in Q1 2022 and held it in 5 quarters. The position peaked at $228K in Q1 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Simplex Trading reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Simplex Trading sold 4,062 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $188K.
  • Simplex Trading first reported a position in DICE Therapeutics, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
  • Simplex Trading's DICE Therapeutics, Inc. Common Stock position peaked at $228K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Simplex Trading's 13F filing for Q3 2023, filed 1 Nov 2023.